GlassScriptPhysician profile
Russell P Cecola
NPI 1639124290
$2,758.60
in general payments reported to CMS, 2019-2025
15 companies · $500 in 2025
The $500 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2020: $151 · 2021: $376 · 2022: $572 · 2023: $361 · 2024: $280 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,106 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,106.35 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $541.21 | 2021-2025 | Pteye Parathyroid Detection System, Propel, Nuvent |
| Glaxosmithkline, LLC. | $484.34 | 2019-2025 | Nucala, Trelegy Ellipta |
| Intersect Ent, INC. | $479.92 | 2019-2021 | |
| Inspire Medical Systems, INC. | $239.31 | 2023-2025 | Inspire |
| Optinose US, INC. | $226.24 | 2019-2025 | |
| Acclarent, INC | $150.43 | 2019-2023 | Acclarent Aera |
| Regeneron Healthcare Solutions, INC. | $133.65 | 2023 | Dupixent |
| Olympus America INC. | $127.35 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $125.37 | 2019-2022 | |
| Medtronic USA, INC. | $67.65 | 2019-2020 | |
| Alk-Abello, INC | $62.24 | 2021 | |
| Amgen INC. | $34.00 | 2025 | |
| Stryker Corporation | $33.98 | 2019-2022 | |
| Integra Lifesciences Corporation | $32.01 | 2024 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Aerin Medical INC. | $20.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Cecola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.